1. Identification of long noncoding RNAs as potential novel diagnosis and prognosis biomarkers in colorectal cancer.
    Rui Wang et al, 2016, J Cancer Res Clin Oncol CrossRef
  2. Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma
    Ji Ma et al, 2017, J Cancer Res Clin Oncol CrossRef
  3. null
    Tianqi Yang et al, 2018 CrossRef
  4. LncRNAs and CircRNAs from the same gene: Masterpieces of RNA splicing
    Ma-Sha Huang et al, 2017, Cancer Letters CrossRef
  5. Long non-coding RNA ANRIL is associated with a poor prognosis of osteosarcoma and promotes tumorigenesis via PI3K/Akt pathway
    Guangyang Yu et al, 2018, Journal of Bone Oncology CrossRef
  6. The long non-coding RNA SPRY4-IT1: An emerging player in tumorigenesis and osteosarcoma.
    Zheng Li et al, 2018, Cell Prolif CrossRef
  7. The role of long non-coding RNA ANRIL in the carcinogenesis of oral cancer by targeting miR-125a
    Luyi Chai et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  8. Long non-coding RNA LOC554202 promotes laryngeal squamous cell carcinoma progression through regulating miR-31
    Shujuan Yang et al, 2018, J. Cell. Biochem. CrossRef
  9. SNP rs2071095 in LincRNA H19 is associated with breast cancer risk
    Ping Cui et al, 2018, Breast Cancer Res Treat CrossRef
  10. Clinical Values of Long Non-coding RNAs in Bladder Cancer: A Systematic Review
    Guoming Su et al, 2018, Front. Physiol. CrossRef
  11. Long Non-Coding RNAs in Obesity-Induced Cancer
    Mabel Yau et al, 2018, ncRNA CrossRef
  12. Down-regulation of long non-coding RNA ANRIL inhibits the proliferation, migration and invasion of cervical cancer cells
    Wei-Yi Zhang et al, 2018, CBM CrossRef
  13. lncRNAs in Non-Malignant Tissue Have Prognostic Value in Colorectal Cancer.
    Alena Opattova, 0 CrossRef
  14. Antisense Non-Coding RNA in the INK4 Locus (ANRIL) in Human Cancers
    Mohammad Taheri et al, 2018, Int J Cancer Manag CrossRef
  15. BPLLDA: Predicting lncRNA-Disease Associations Based on Simple Paths With Limited Lengths in a Heterogeneous Network
    Xiaofang Xiao et al, 2018, Front. Genet. CrossRef
  16. ANRIL promotes chemoresistance via disturbing expression of ABCC1 by regulating the expression of Let-7a in colorectal cancer
    Zhen Zhang et al, 2018, Biosci. Rep. CrossRef
  17. Long noncoding RNA ANRIL contributes to the development of ulcerative colitis by miR-323b-5p/TLR4/MyD88/NF-κB pathway
    Cuixia Qiao et al, 2018, Biochemical and Biophysical Research Communications CrossRef
  18. Effect of lncRNA ANRIL knockdown on proliferation and cisplatin chemoresistance of osteosarcoma cells in vitro
    Guowei Li et al, 2019, Pathology - Research and Practice CrossRef
  19. Interference of the long noncoding RNA CDKN2B‐AS1 upregulates miR‐181a‐5p/TGFβI axis to restrain the metastasis and promote apoptosis and senescence of cervical cancer cells
    Lihong Zhu et al, 2019, Cancer Med CrossRef
  20. Long noncoding RNA CDKN2B-AS1 interacts with miR-411–3p to regulate ovarian cancer in vitro and in vivo through HIF-1a/VEGF/P38 pathway
    Yan Wang et al, 2019, Biochemical and Biophysical Research Communications CrossRef
  21. Diagnostic and prognostic potential of tissue and circulating long non-coding RNAs in colorectal tumors
    Orsolya Galamb et al, 2019, WJG CrossRef
  22. The over expression of long non-coding RNA ANRIL promotes epithelial-mesenchymal transition by activating the ATM-E2F1 signaling pathway in pancreatic cancer: An in vivo and in vitro study
    Shi Chen et al, 2017, International Journal of Biological Macromolecules CrossRef
  23. The prognostic value of abnormally expressed lncRNAs in colorectal cancer: A meta-analysis
    June Wang et al, 2017, PLoS ONE CrossRef
  24. null
    Ramesh Choudhari et al, 2019 CrossRef
  25. Long noncoding RNA ANRIL as a novel biomarker of lymph node metastasis and prognosis in human cancer: a meta-analysis
    Han Wang et al, 2018, Oncotarget CrossRef
  26. Identification of a RNA-Seq based prognostic signature with five lncRNAs for lung squamous cell carcinoma
    Rui-Xue Tang et al, 2017, Oncotarget CrossRef
  27. Long non-coding RNAs in cutaneous melanoma: clinical perspectives
    Eva Hulstaert et al, 2017, Oncotarget CrossRef
  28. Comprehensive investigation of a novel differentially expressed lncRNA expression profile signature to assess the survival of patients with colorectal adenocarcinoma
    Jiang-Hui Zeng et al, 2017, Oncotarget CrossRef
  29. Long non-coding RNAs: a rising biotarget in colorectal cancer
    Jian Luo et al, 2017, Oncotarget CrossRef
  30. LncRNAs: the bridge linking RNA and colorectal cancer
    Yanfei Yang et al, 2017, Oncotarget CrossRef
  31. Roles of long noncoding RNAs in colorectal cancer metastasis
    He Li et al, 2017, Oncotarget CrossRef
  32. Long non-coding RNAs: Key regulators in oxaliplatin resistance of colorectal cancer.
    Fang-Fang Qi et al, 2020, Biomed Pharmacother CrossRef
  33. LncRNA ANRIL acts as a modular scaffold of WDR5 and HDAC3 complexes and promotes alteration of the vascular smooth muscle cell phenotype
    Chengxin Zhang et al, 2020, Cell Death Dis CrossRef
  34. Qingjie Fuzheng Granule Inhibited the Migration and Invasion of Colorectal Cancer Cells by Regulating the lncRNA ANRIL/let-7a/TGF-β1/Smad Axis
    Ling Zhang et al, 2020, Evidence-Based Complementary and Alternative Medicine CrossRef
  35. Association of a novel seven-gene expression signature with the disease prognosis in colon cancer patients
    Haojie Yang et al, 2019, Aging CrossRef
  36. Long noncoding RNA ANRIL as a novel biomarker in human cancer
    Ning Lou et al, 2020, Future Oncology CrossRef
  37. Long Noncoding RNA and Cancer: A New Paradigm.
    Arunoday Bhan et al, 2017, Cancer Res CrossRef
  38. Multi-Label Fusion Collaborative Matrix Factorization for Predicting LncRNA-Disease Associations
    Ming-Ming Gao et al, 2021, IEEE J. Biomed. Health Inform. CrossRef
  39. Non-coding RNAs in melanoma: Biological functions and potential clinical applications
    Qiu Peng et al, 2021, Molecular Therapy - Oncolytics CrossRef
  40. Long Non-Coding RNA ANRIL as a Potential Biomarker of Chemosensitivity and Clinical Outcomes in Osteosarcoma
    Adam M. Lee et al, 2021, IJMS CrossRef
  41. Highly Expressed Antisense Noncoding RNA in the INK4 Locus Promotes Growth and Invasion of Renal Clear Carcinoma Cells via the β-Catenin Pathway
    Qingchun Li et al, 2017, oncol res CrossRef
  42. The expression of LRRN4 was correlated with the progression and prognosis of colon adenocarcinoma (COAD) patients.
    Yuxian Zhang et al, 2021, Genet Mol Biol CrossRef
  43. ANRIL as a prognostic biomarker in colon pre-cancerous lesion detection via non-invasive sampling
    Shadi Sadri et al, 2022, Genes Genet. Syst. CrossRef
  44. Role of Non-coding RNA as a Biomarker of Response to Therapeutic Agents in Colorectal Cancer
    Roghayeh Mahmoudi et al, 2022, Jentashapir J Cell Mol Biol CrossRef
  45. Babao Dan inhibits lymphangiogenesis of gastric cancer in vitro and in vivo via lncRNA-ANRIL/VEGF-C/VEGFR-3 signaling axis
    Jianhua Guan et al, 2022, Biomedicine & Pharmacotherapy CrossRef
  46. High expression of ANRIL correlated with the poor prognosis in patients with cancer: A meta-analysis
    Yun Liu et al, 2022 CrossRef
  47. Identification of an m6A‐related lncRNA prognostic signature in colorectal cancer
    Zhi‐Liang Shi et al, 2022, J Biochem & Molecular Tox CrossRef
  48. Long noncoding RNAs as diagnostic biomarkers associated with cancer phenotypes
    Huili Luo et al, 2018 CrossRef
  49. Evaluation of rs10811661 polymorphism in CDKN2A / B in colon and gastric cancer
    Maria Beihaghi et al, 2023, BMC Cancer CrossRef
  50. Long Non-coding RNA ANRIL and Its Role in the Development of Age-Related Diseases
    Feiyan Shou et al, 2024, Mol Neurobiol CrossRef